Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Oct 20, 2016 at 9:15 AM EDT

iRhythm Technologies Announces IPO Pricing

iRhthym Technologies has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).

Chris Lange | Oct 19, 2016 at 3:43 PM EDT

Puma Biotech Gears Up for Secondary Offering

Puma Biotechnology, Inc. (NYSE: PBYI) recently filed with the U.S. Securities and Exchange Commission (SEC) for a secondary offering. No…

Chris Lange | Oct 19, 2016 at 11:25 AM EDT

Nektar Slides on Secondary Offering Pricing

Nektar Therapeutics plans to price 13 million shares at $13.50 for a secondary offering valued up to almost $202 million.

Jon C. Ogg | Oct 18, 2016 at 10:45 AM EDT

Is Settling With an Activist Investor Supposed to Be Bad for Shareholders?

Depomed has settled with Starboard Value in a move that will bring this activist investor fight to a close. At…

Chris Lange | Oct 18, 2016 at 9:15 AM EDT

Johnson & Johnson Remains Flat Despite Earnings Beat

Johnson & Johnson released a better-than-expected third-quarter report before the markets opened on Tuesday.

Lee Jackson | Oct 18, 2016 at 8:25 AM EDT

Jefferies Biotech and Health Care Momentum Stocks to Buy With Big Upside Potential

A new research report from Jefferies notes that when price momentum has been as bad as it has been recently,…

Paul Ausick | Oct 18, 2016 at 7:35 AM EDT

UnitedHealth Raises EPS Forecast as Profits Post Double-Digit Increase

UnitedHealth Group reported better-than-expected third-quarter 2016 results before markets opened Tuesday morning.

Chris Lange | Oct 17, 2016 at 2:56 PM EDT

ContraVir Continues to Win on More Positive HBV Updates

ContraVir Pharmaceuticals watched its shares make a handy gain in Monday’s session after the company announced a positive development in…

Chris Lange | Oct 17, 2016 at 12:15 PM EDT

What to Look for in Johnson & Johnson Earnings

Johnson & Johnson is expected to release its most recent earnings report before the markets open on Tuesday.

Chris Lange | Oct 17, 2016 at 10:45 AM EDT

Will PTC’s FDA Denial Interrupt Its Growth Plans?

PTC Therapeutics shares took a dive early on Monday after the company announced a key FDA decision that wasn’t good.

Chris Lange | Oct 13, 2016 at 4:08 PM EDT

How ContraVir Pharma Won Big on Its HBV Interim Results

ContraVir Pharmaceuticals Inc. (NASDAQ: CTRV) is watching its shares climb on Thursday after the company reported positive interim data from…

Lee Jackson | Oct 13, 2016 at 10:40 AM EDT

Top 5 Jefferies Big Pharma Stock Picks for Q4

A new Jefferies research report features top pharmaceutical picks for the fourth quarter. Any of these top picks make good…

Chris Lange | Oct 13, 2016 at 10:10 AM EDT

Fluidigm Stumbles on Preliminary Q3 Results

After Fluidigm announced preliminary results for its third quarter on Wednesday, investors sent the shares sharply lower.

Chris Lange | Oct 13, 2016 at 9:05 AM EDT

Why Ocular Therapeutix Is Winning Big With Its Regeneron Collaboration

Ocular Therapeutix and Regeneron are attempting to develop a sustained release formulation of aflibercept that is suitable for advancement into…

Chris Lange | Oct 12, 2016 at 10:20 AM EDT

IntelliPharmaCeutics Inks New Licensing Deal With Mallinckrodt

Shares of IntelliPharmaCeutics soared after the company reported a new licensing deal with Mallinckrodt.

1 … 189 190 191 192 193 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

iRhythm Technologies Announces IPO Pricing

Puma Biotech Gears Up for Secondary Offering

Nektar Slides on Secondary Offering Pricing

Is Settling With an Activist Investor Supposed to Be Bad for Shareholders?

Johnson & Johnson Remains Flat Despite Earnings Beat

Jefferies Biotech and Health Care Momentum Stocks to Buy With Big Upside Potential

UnitedHealth Raises EPS Forecast as Profits Post Double-Digit Increase

ContraVir Continues to Win on More Positive HBV Updates

What to Look for in Johnson & Johnson Earnings

Will PTC’s FDA Denial Interrupt Its Growth Plans?

How ContraVir Pharma Won Big on Its HBV Interim Results

Top 5 Jefferies Big Pharma Stock Picks for Q4

Fluidigm Stumbles on Preliminary Q3 Results

Why Ocular Therapeutix Is Winning Big With Its Regeneron Collaboration

IntelliPharmaCeutics Inks New Licensing Deal With Mallinckrodt

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

iRhythm Technologies Announces IPO Pricing

Puma Biotech Gears Up for Secondary Offering

Nektar Slides on Secondary Offering Pricing

Is Settling With an Activist Investor Supposed to Be Bad for Shareholders?

Johnson & Johnson Remains Flat Despite Earnings Beat

Jefferies Biotech and Health Care Momentum Stocks to Buy With Big Upside Potential

UnitedHealth Raises EPS Forecast as Profits Post Double-Digit Increase

ContraVir Continues to Win on More Positive HBV Updates

What to Look for in Johnson & Johnson Earnings

Will PTC’s FDA Denial Interrupt Its Growth Plans?

How ContraVir Pharma Won Big on Its HBV Interim Results

Top 5 Jefferies Big Pharma Stock Picks for Q4

Fluidigm Stumbles on Preliminary Q3 Results

Why Ocular Therapeutix Is Winning Big With Its Regeneron Collaboration

IntelliPharmaCeutics Inks New Licensing Deal With Mallinckrodt

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check